These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24647103)

  • 1. Development of a physiologically-based pharmacokinetic model of the rat central nervous system.
    Badhan RK; Chenel M; Penny JI
    Pharmaceutics; 2014 Mar; 6(1):97-136. PubMed ID: 24647103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics.
    Shen DD; Artru AA; Adkison KK
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1825-57. PubMed ID: 15381336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations.
    Saleh MAA; Loo CF; Elassaiss-Schaap J; De Lange ECM
    J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):725-741. PubMed ID: 34142308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kinetic analysis of the disposition of hydrophilic drugs in the central nervous system (CNS): prediction of the CNS disposition from the transport properties in the blood-brain and blood-cerebrospinal fluid barriers].
    Suzuki H; Sugiyama Y
    Yakugaku Zasshi; 1994 Dec; 114(12):950-71. PubMed ID: 7869236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF as a surrogate for assessing CNS exposure: an industrial perspective.
    Lin JH
    Curr Drug Metab; 2008 Jan; 9(1):46-59. PubMed ID: 18220571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational CNS Steady-State Drug Disposition Model in Rats, Monkeys, and Humans for Quantitative Prediction of Brain-to-Plasma and Cerebrospinal Fluid-to-Plasma Unbound Concentration Ratios.
    Sato S; Matsumiya K; Tohyama K; Kosugi Y
    AAPS J; 2021 Jun; 23(4):81. PubMed ID: 34085128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation.
    Caruso A; Alvarez-Sánchez R; Hillebrecht A; Poirier A; Schuler F; Lavé T; Funk C; Belli S
    Biochem Pharmacol; 2013 Jun; 85(11):1684-99. PubMed ID: 23454189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Minimal Physiologically Based Pharmacokinetic Model to Characterize CNS Distribution of Metronidazole in Neuro Care ICU Patients.
    Chauzy A; Bouchène S; Aranzana-Climent V; Clarhaut J; Adier C; Grégoire N; Couet W; Dahyot-Fizelier C; Marchand S
    Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of utility of cerebrospinal fluid drug concentration as a surrogate for interstitial fluid concentration using microdialysis coupled with cisternal cerebrospinal fluid sampling in wild-type and Mdr1a(-/-) rats.
    Nagaya Y; Nozaki Y; Takenaka O; Watari R; Kusano K; Yoshimura T; Kusuhara H
    Drug Metab Pharmacokinet; 2016 Feb; 31(1):57-66. PubMed ID: 26830080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system pharmacokinetics of the Mdr1 P-glycoprotein substrate CP-615,003: intersite differences and implications for human receptor occupancy projections from cerebrospinal fluid exposures.
    Venkatakrishnan K; Tseng E; Nelson FR; Rollema H; French JL; Kaplan IV; Horner WE; Gibbs MA
    Drug Metab Dispos; 2007 Aug; 35(8):1341-9. PubMed ID: 17470526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
    Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
    Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of In Vitro Passive Permeability in a P-gp-transfected LLC-PK1 Model on the Prediction of the Rat and Human Unbound Brain-to-Plasma Concentration Ratio.
    Nicolaï J; Chapy H; Gillent E; Saunders K; Ungell AL; Nicolas JM; Chanteux H
    Pharm Res; 2020 Aug; 37(9):175. PubMed ID: 32856111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A physiologically based modeling strategy during preclinical CNS drug development.
    Ball K; Bouzom F; Scherrmann JM; Walther B; Declèves X
    Mol Pharm; 2014 Mar; 11(3):836-48. PubMed ID: 24446829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of the unbound brain concentration of P-glycoprotein substrates or nonsubstrates by a serial cerebrospinal fluid sampling technique in rats.
    Mariappan TT; Kurawattimath V; Gautam SS; Kulkarni CP; Kallem R; Taskar KS; Marathe PH; Mandlekar S
    Mol Pharm; 2014 Feb; 11(2):477-85. PubMed ID: 24380373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico prediction of brain exposure: drug free fraction, unbound brain to plasma concentration ratio and equilibrium half-life.
    Spreafico M; Jacobson MP
    Curr Top Med Chem; 2013; 13(7):813-20. PubMed ID: 23578025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of Antibody Pharmacokinetics in the Brain Following Intra-CNS Administration and Development of PBPK Model to Characterize the Data.
    Wu S; Chang HY; Chowdhury EA; Huang HW; Shah DK
    AAPS J; 2024 Mar; 26(2):29. PubMed ID: 38443635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: Estimating time varying CSF drug concentrations and their variability using in vitro data.
    Gaohua L; Neuhoff S; Johnson TN; Rostami-Hodjegan A; Jamei M
    Drug Metab Pharmacokinet; 2016 Jun; 31(3):224-33. PubMed ID: 27236639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Practical Perspective on the Evaluation of Small Molecule CNS Penetration in Drug Discovery.
    Huang L; Wells MC; Zhao Z
    Drug Metab Lett; 2019; 13(2):78-94. PubMed ID: 30854983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of bottom-up modeling of the blood-brain barrier to improve brain penetration prediction via physiologically based pharmacokinetic modeling.
    Bowman C; Ma F; Mao J; Plise E; Chen E; Liu L; Zhang S; Chen Y
    Biopharm Drug Dispos; 2023 Feb; 44(1):60-70. PubMed ID: 36630933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of P-Glycoprotein-Mediated Active Efflux on Drug Distribution into Lumbar Cerebrospinal Fluid in Nonhuman Primates.
    Nagaya Y; Katayama K; Kusuhara H; Nozaki Y
    Drug Metab Dispos; 2020 Nov; 48(11):1183-1190. PubMed ID: 32862147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.